CEimpact Podcast
The CEimpact Podcast features two shows - GameChangers and Precept2Practice!
The GameChangers Clinical Conversations podcast, hosted by Josh Kinsey, features the latest game-changing pharmacotherapy advances impacting patient care. New episodes arrive every Monday. Pharmacist By Design™ subscribers can earn CE credit for each episode.
The Precept2Practice podcast, hosted by Kathy Scott, features information and resources for preceptors of students and residents. New episodes arrive on the third Wednesday of every month. Preceptor By Design™ subscribers can earn CE credit for each episode.
To support our shows, give us a follow and check back each week for our latest episodes.
CEimpact Podcast
A First Treatment for Celiac Disease?
Celiac disease is of the most common auto-immune diseases in the world. The only current treatment is maintaining a strict gluten-free diet. Join host, Geoff Wall, as he discusses the results of a phase 2 study investigating a novel pharmacologic treatment of Celiac disease.
The GameChanger
Celiac disease is common and has a myriad of symptoms. A new drug may offer a way for patients with Celiac disease to eat gluten without issue.
Show Segments
00:00 - Introductions
00:50 - The Effects of Celiac Disease
03:45 - Why Celiac Causes Problems
09:08 - Latiglutenase Study Background
14:48 - The GameChanger: Latiglutenase Study Results
19:11 - Connecting to Practice
21:31 - Closing Remarks
Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
References and Resources
Murray JA, Syage JA, Wu TT, et al. Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients With Celiac Disease Exposed to a Gluten Challenge. Gastroenterology. 2022 Dec;163(6):1510-1521.e6. doi: 10.1053/j.gastro.2022.07.071. Epub 2022 Aug 2. PMID: 35931103; PMCID: PMC9707643.
Redeem your CPE or CME here
Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
CE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the extraintestinal manifestations of Celiac disease
2. Discuss the Murray et al study and its implications in patients with Celiac disease
0.05 CEU/0.5 Hr
UAN: 0107-0000-23-024-H01-P
Initial release date: 01/16/2023
Expiration date: 01/16/2024
Additional CPE and CME details can be found here.